FindTrial
Sign In

Observational study of first-line therapy including cetuximab in patients with metastatic colorectal cancer

Observational study of first-line therapy including cetuximab in patients with metastatic colorectal cancer - Cetuximab observational study as first-line therapy (CORAL study)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000007275
Enrollment
1000
Registered
2012-02-13
Start date
2011-12-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic colorectal cancer

Interventions

None listed

Sponsors

Public Health Research Foundation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Patients with metastatic colorectal cancer before registration of this study (2)Patients with ECOG PS 0-2 (3)Patients with received treatment as 1st-line therapy including cetuximab

Exclusion criteria

Exclusion criteria: (1)Patients with double cancers affecting prognosis (2)Patients received neo-adjuvant. chemotherapy for resectable liver metastasis (3)Patients judged ineligible to participate in this study by an attending physician

Design outcomes

Primary

MeasureTime frame
Status of therapy Safety Efficacy—

Countries

Japan

Contacts

Public ContactAkira Yamao

Public Health Research Foundation Comprehensive Support Project for Clinical Research

cspor-office@csp.or.jp03-5287-2636

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026